Two-year evolution of latent rheumatic heart disease in Malawi.
Amy E SanyahumbiAndrea BeatonDanielle GuffeyMina C HosseinipourMelissa KarlstenCharles G MinardDaniel J PennyCraig A SablePeter N KazembePublished in: Congenital heart disease (2019)
Borderlines had a very low progression rate to definite RHD. A strength of our study was a high retention rate (98%). Longer follow-up is needed to determine expected disease evolution.